Andrew Tomlin

ORCID: 0000-0002-0967-9860
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Primary Care and Health Outcomes
  • Opioid Use Disorder Treatment
  • Asthma and respiratory diseases
  • Healthcare Policy and Management
  • Antibiotic Use and Resistance
  • Pharmaceutical Practices and Patient Outcomes
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pain Management and Opioid Use
  • Delphi Technique in Research
  • Medical Coding and Health Information
  • Pharmaceutical studies and practices
  • Health Sciences Research and Education
  • Poisoning and overdose treatments
  • Child and Adolescent Health
  • Heart Failure Treatment and Management
  • Machine Learning in Healthcare
  • Health Promotion and Cardiovascular Prevention
  • Drug-Induced Adverse Reactions
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmacovigilance and Adverse Drug Reactions
  • Healthcare Systems and Technology
  • Clinical practice guidelines implementation
  • Schizophrenia research and treatment
  • Emergency and Acute Care Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research

University of Auckland
2019-2024

The Family Centre
2020

National Institute of Public Health
2019

Auckland City Hospital
2019

The University of Melbourne
2015

Guy's and St Thomas' NHS Foundation Trust
2013

Level (Czechia)
2012

Indiana University – Purdue University Indianapolis
2010

Royal New Zealand College of General Practitioners
1999-2008

University of Otago
1999-2008

Abstract Previous studies report an association between maternal diabetes mellitus (MDM) and attention-deficit/hyperactivity disorder (ADHD), often overlooking unmeasured confounders such as shared genetics environmental factors. We therefore conducted a multinational cohort study with linked mother–child pairs data in Hong Kong, New Zealand, Taiwan, Finland, Iceland, Norway Sweden to evaluate associations different MDM (any MDM, gestational (GDM) pregestational (PGDM)) ADHD using Cox...

10.1038/s41591-024-02917-8 article EN cc-by Nature Medicine 2024-04-08

10.24251/hicss.2025.448 article EN Proceedings of the ... Annual Hawaii International Conference on System Sciences/Proceedings of the Annual Hawaii International Conference on System Sciences 2025-01-01

Abstract Background Acute colonic diverticulitis is placing an increasing strain on our health care resources. Measurement of the problem difficult at a regional level, yet essential to improve and optimize treatment this condition. Therefore, we aimed use Australian state‐level administrative data determine current practice outcomes in major metropolitan hospitals. Methods Coding algorithms designed increase yield accuracy were used find emergency admissions from V ictorian A dmitted E...

10.1111/ans.13126 article EN ANZ Journal of Surgery 2015-04-22

Background Atrial fibrillation is a major risk factor for stroke and heart disease but there limited information on its prevalence in New Zealand primary care or the treatment provided to manage thromboembolic risk. Our aim was estimate of atrial fibrillation, assess patient thromboembolism evaluate appropriateness reduction using antiplatelet oral anticoagulation therapy. Design A retrospective cohort study utilising electronic medical records 739,000 patients registered with 170 general...

10.1177/2047487316674830 article EN European Journal of Preventive Cardiology 2016-10-20

Abstract Objective To investigate whether delayed or no treatment was associated with increased mortality and morbidity risks in people newly diagnosed epilepsy. Methods We examined New Zealand hospitalization antiseizure medication prescription data from 2007‐2015. Mortality hospital‐diagnosed morbidities were compared between patients immediately treated after epilepsy diagnosis, a delay, untreated for the duration of follow‐up, adjusted age, sex, ethnicity. Results Three thousand three...

10.1111/epi.16435 article EN Epilepsia 2020-01-24

10.1016/j.diabres.2007.12.017 article EN Diabetes Research and Clinical Practice 2008-02-20

Asthma is one of the most common long-term conditions in world, with New Zealand (NZ) having highest rates asthma symptoms. Despite significant burden NZ, there a lack data on exacerbation NZ and how these have varied over time. This study national population-based between 2010 2019, explores vary amongst different demographic groups.A retrospective observational cohort covering ten years 2010-2019 to determine prevalence, hospitalisation rates, using de-identified from five healthcare...

10.1016/j.rmed.2023.107365 article EN cc-by-nc-nd Respiratory Medicine 2023-07-21

ABSTRACT Aim While the prevalence of end stage kidney disease in New Zealand (NZ) is well defined, chronic (CKD) NZ unknown. To estimate and risk factors for CKD southern region Zealand. Methods A retrospective electronic health record cohort study using data from Southern Primary Care register covering 94% population. Patients, 20 years or older were identified linked to laboratory results serum creatinine urinary albumin excretion. Chronic was defined as an estimated glomerular filtration...

10.1111/nep.13395 article EN Nephrology 2018-05-02

New Zealand (NZ) implemented some of the strictest restrictions during novel coronavirus pandemic (coronavirus disease 2019 [COVID-19]), caused by severe acute respiratory syndrome 2 (SARS-CoV-2). How this impacted asthma exacerbation rates in NZ is unknown.We sought to explore effects COVID-19 on exacerbations 2020.We used a population-based, interrupted time series examine impact first lockdown rate. The primary outcome measure was change monthly rate, defined as hospitalization and/or...

10.1016/j.jacig.2023.100157 article EN cc-by-nc-nd Journal of Allergy and Clinical Immunology Global 2023-07-26

Abstract Objectives Opioid use has increased globally, dramatically increasing opioid overdose, dependence, abuse and mortality. Limited research is available on patterns in older adults New Zealand internationally. This study aims to address this gap by determining the incidence prevalence of among (age ≥65 years) from 2007 2018. Methods was a population‐based retrospective cohort conducted using national administrative healthcare databases. The annual (2008–2018) (2007–2018) were...

10.1111/ajag.13278 article EN cc-by-nc Australasian Journal on Ageing 2024-01-20

Laboratory tests for inflammatory response, thyroid function and infectious diarrhoea were not being ordered as recommended by clinical guidelines.To measure changes in community laboratory-test ordering following marketing programmes promoting guidelines recommendations.Controlled before-and-after study involving 2 years of national laboratory payment data before after each intervention. Comparisons with doctors the same but receiving interventions.New Zealand primary care.3161, 3140 3335...

10.1136/bmjqs.2010.048124 article EN BMJ Quality & Safety 2011-01-12

Introduction: While a number of developed countries have witnessed decline in carbon monoxide (CO) deaths and increasing numbers opioid-related fatalities, it is not known whether these or other trends occurred New Zealand. The aim this study was, therefore, to review due poisoning Zealand, describe the causative substances, identify any trends.Methods: Retrospective reviewing Zealand's poison-related death findings recorded National Coronial Information System (NCIS) database over 6-year...

10.1080/15563650.2019.1582777 article EN Clinical Toxicology 2019-02-26

Variation in prescription costs between general practices and within over time is poorly understood.From New Zealand's national health data collections, we extracted dispensed medicines for 1045 2011 917 continuously existing 2008-11. Using indirect standardization to account patient demographics morbidity, a standardized prescribing cost ratio (SPR: the of actual : expected costs) was calculated each practice year. Case studies three outlier clinics explored reasons their status.SPRs ranged...

10.1093/pubmed/fdu116 article EN Journal of Public Health 2015-01-18
Coming Soon ...